
What a great couple of days at #ACT2026! 🧬 We are looking forward to today's plenary sessions and to continuing the discussions with more people in the audience. #ACT2026 #Toxicology #RNAseq #DrugSafety #AlitheaGenomics


What a great couple of days at #ACT2026! 🧬 We are looking forward to today's plenary sessions and to continuing the discussions with more people in the audience. #ACT2026 #Toxicology #RNAseq #DrugSafety #AlitheaGenomics

How do you go from a 3D liver model to a toxicity prediction you can trust? Join our talk, "DRUG-seq in Practice: Ultra-High-Throughput Transcriptomics for Compound Triage and Safety Liability Assessment", on Monday, 16 November from 12:00 to 12:55.

500,000 samples. More than a year of screening in 14 weeks? Tomorrow, November 10, Alithea Genomics and Nuvisan will share experimental data comparing 384- and 1536-well DRUG-seq. 🔗 eu1.hubs.ly/H0zL4RD0 #DRUGseq #DrugDiscovery #Transcriptomics #HighThroughputScreening

Our Senior Data Scientist, Alexandre Coudray, PhD, took the stage at the Olympic Museum in Lausanne to present “Connecting Chemical and Genetic Perturbation Signatures at Screening Scale.” #Transcriptomics #FunctionalGenomics #DrugDiscovery #EPFL

At the EPFL Latsis Symposium 2026, our Senior Data Scientist, Alexandre Coudray, will explore how high-throughput transcriptomics enables the systematic comparison of transcriptional signatures generated by compound treatments and genetic perturbations.

Great discussions at #ASHG2026! 🧬 Our Alithea Genomics team joined our partners at Revvity to connect with researchers exploring the links between genetic variation, gene function, and disease mechanisms. #ASHG2026 #DRUGseq #Transcriptomics #DrugDiscovery

Can a multiplexed total RNA-seq workflow deliver the same biology as standard library prep kits? Our new tech note benchmarks MERCURIUS™ Total BRB-seq against NEBNext® and Watchmaker total RNA kits. Link: eu1.hubs.ly/H0zl_QC0 #RNAseq

4× the wells. But what happens to the data? Join Alithea + Nuvisan on Nov 10 for 384 vs. 1536-well DRUG-seq performance data, MoA signatures, and practical screening insights. Register: eu1.hubs.ly/H0zk3Y90 #DRUGseq #DrugDiscovery #Transcriptomics #HighThroughputScreening

Big questions in human genetics deserve powerful tools to answer them. 🧬 Meet Andrea and Daniela and explore how scalable, high-throughput transcriptomics can bring deeper biological insights to your research. #ASHG2026 #FunctionalGenomics #DrugDiscovery #RNAseq

Over 180 people have registered so far for this Wednesday's webinar titled: From Target Discovery to Toxicology. Register: eu1.hubs.ly/H0zbLJs0 #DrugDiscovery #CellPainting #Transcriptomics

We're hiring an NGS Specialist in the US! 📍 Frederick, MD, USA | Full-time, on-site Interested? Apply here: eu1.hubs.ly/H0y_RgB0 #NGS #RNAseq #Genomics #BiotechJobs

Join us at ELRIG Drug Discovery 2026! Our team will present three scientific posters exploring how high-throughput transcriptomics can advance compound screening, MoA studies, and toxicity assessment. #ELRIG2026 #DrugDiscovery #Transcriptomics #HighThroughputScreening

Join Alithea Genomics and Axxam to explore what Cell Painting and DRUG-seq each reveal through two case studies on target validation and toxicology. Register: eu1.hubs.ly/H0yTk0l0 #DrugDiscovery #CellPainting #Transcriptomics #Toxicology

Last chance to join our next webinar with Senior Data Scientist Alexandre Coudray, PhD, and learn the key steps of MERCURIUS™ DRUG-seq data analysis. 👉 Register here: eu1.hubs.ly/H0ygp4Y0 #Bioinformatics #DrugDiscovery #RNAseq

Join our upcoming webinar with Senior Data Scientist Alexandre Coudray, PhD. Learn the key steps of MERCURIUS™ DRUG-seq data analysis, from raw FASTQ files to QC and differential expression. 👉 Register here: eu1.hubs.ly/H0ycjph0 #Bioinformatics #DrugDiscovery #RNA-seq

Alithea Genomics would like to invite you to join us at the EPFL Latsis Symposium. 📍 Olympic Museum, Lausanne 📅 October 29–30, 2026 Register here: eu1.hubs.ly/H0y7PRw0 #SingleCell #MultiOmics #ComputationalBiology #EPFL